455 related articles for article (PubMed ID: 24284419)
1. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.
Dowlatshahi EA; Wakkee M; Arends LR; Nijsten T
J Invest Dermatol; 2014 Jun; 134(6):1542-1551. PubMed ID: 24284419
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and odds of depression in patients with vitiligo: a meta-analysis.
Wang G; Qiu D; Yang H; Liu W
J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1343-1351. PubMed ID: 29222958
[TBL] [Abstract][Full Text] [Related]
3. Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians.
Read C; Armstrong AW
JAMA Dermatol; 2020 Jul; 156(7):754-762. PubMed ID: 32374350
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis.
Jalenques I; Bourlot F; Martinez E; Pereira B; D'Incan M; Lauron S; Rondepierre F
Acta Derm Venereol; 2022 Aug; 102():adv00769. PubMed ID: 35604236
[TBL] [Abstract][Full Text] [Related]
6. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.
Cox GR; Callahan P; Churchill R; Hunot V; Merry SN; Parker AG; Hetrick SE
Cochrane Database Syst Rev; 2012 Nov; 11():CD008324. PubMed ID: 23152255
[TBL] [Abstract][Full Text] [Related]
7. Clinical risk factors for depressive syndrome in Type 2 diabetes: the Fremantle Diabetes Study.
Bruce DG; Davis WA; Starkstein SE; Davis TME
Diabet Med; 2018 Jul; 35(7):903-910. PubMed ID: 29608787
[TBL] [Abstract][Full Text] [Related]
8. An Italian study on psoriasis and depression.
Esposito M; Saraceno R; Giunta A; Maccarone M; Chimenti S
Dermatology; 2006; 212(2):123-7. PubMed ID: 16484818
[TBL] [Abstract][Full Text] [Related]
9. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A
J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis.
Wang J; Wu X; Lai W; Long E; Zhang X; Li W; Zhu Y; Chen C; Zhong X; Liu Z; Wang D; Lin H
BMJ Open; 2017 Aug; 7(8):e017173. PubMed ID: 28838903
[TBL] [Abstract][Full Text] [Related]
11. Self-reported depressive symptoms in dental students: Systematic review with meta-analysis.
Muniz FWMG; Maurique LS; Toniazzo MP; Silva CF; Casarin M
J Dent Educ; 2021 Feb; 85(2):135-147. PubMed ID: 32929744
[TBL] [Abstract][Full Text] [Related]
12. Clinical depression in untreated obstructive sleep apnea: examining predictors and a meta-analysis of prevalence rates.
Jackson ML; Tolson J; Bartlett D; Berlowitz DJ; Varma P; Barnes M
Sleep Med; 2019 Oct; 62():22-28. PubMed ID: 31525678
[TBL] [Abstract][Full Text] [Related]
13. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
Leblé N; Radon L; Rabot M; Godart N
Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005-2008.
Shim RS; Baltrus P; Ye J; Rust G
J Am Board Fam Med; 2011; 24(1):33-8. PubMed ID: 21209342
[TBL] [Abstract][Full Text] [Related]
15. The association between the clinical diversity of psoriasis and depressive symptoms: the HUNT Study, Norway.
Modalsli EH; Åsvold BO; Snekvik I; Romundstad PR; Naldi L; Saunes M
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2062-2068. PubMed ID: 28662282
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbance in psoriasis: a case-controlled study.
Jensen P; Zachariae C; Skov L; Zachariae R
Br J Dermatol; 2018 Dec; 179(6):1376-1384. PubMed ID: 29704428
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression.
Zhang MW; Ho RC; Cheung MW; Fu E; Mak A
Gen Hosp Psychiatry; 2011; 33(3):217-23. PubMed ID: 21601717
[TBL] [Abstract][Full Text] [Related]
18. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease.
van den Brink G; Stapersma L; Vlug LE; Rizopolous D; Bodelier AG; van Wering H; Hurkmans PCWM; Stuyt RJL; Hendriks DM; van der Burg JAT; Utens EMWJ; Escher JC
Aliment Pharmacol Ther; 2018 Aug; 48(3):358-369. PubMed ID: 29897134
[TBL] [Abstract][Full Text] [Related]
19. Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study.
Martínez-Ortega JM; Nogueras P; Muñoz-Negro JE; Gutiérrez-Rojas L; González-Domenech P; Gurpegui M
J Psychosom Res; 2019 Sep; 124():109780. PubMed ID: 31443809
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.
Zhou X; Teng T; Zhang Y; Del Giovane C; Furukawa TA; Weisz JR; Li X; Cuijpers P; Coghill D; Xiang Y; Hetrick SE; Leucht S; Qin M; Barth J; Ravindran AV; Yang L; Curry J; Fan L; Silva SG; Cipriani A; Xie P
Lancet Psychiatry; 2020 Jul; 7(7):581-601. PubMed ID: 32563306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
